Zinc Fingers nuclease News and Research

RSS
Sigma Life Science releases breast cancer-specific knockout and knockin cell lines for drug research

Sigma Life Science releases breast cancer-specific knockout and knockin cell lines for drug research

Advancements in use of zinc finger nucleases to produce genetically modified pigs

Advancements in use of zinc finger nucleases to produce genetically modified pigs

Sigma introduces CompoZr Targeted Integration Kit – mRosa26

Sigma introduces CompoZr Targeted Integration Kit – mRosa26

Scientists use two methods to manipulate disease-causing mutations in stem cells

Scientists use two methods to manipulate disease-causing mutations in stem cells

STSI receives NIH grant to conduct heart-based research

STSI receives NIH grant to conduct heart-based research

In vivo genome editing restores hemostasis in mouse model of blood clotting disorder

In vivo genome editing restores hemostasis in mouse model of blood clotting disorder

Sangamo announces presentations of ZFP Therapeutics data at ASGCT 2011

Sangamo announces presentations of ZFP Therapeutics data at ASGCT 2011

Sangamo's preclinical ZFN-gene modification studies for HIV/AIDS treatment presented at CROI

Sangamo's preclinical ZFN-gene modification studies for HIV/AIDS treatment presented at CROI

Positive preliminary data from SB-728-902 Phase 1 trial against HIV/AIDS presented at 18th CROI

Positive preliminary data from SB-728-902 Phase 1 trial against HIV/AIDS presented at 18th CROI

Sangamo completes enrollment in SB-509-901 Phase 2b clinical trial in diabetic neuropathy

Sangamo completes enrollment in SB-509-901 Phase 2b clinical trial in diabetic neuropathy

Nanomedicine Center for Nucleoprotein Machines receives $16.1 million NIH award

Nanomedicine Center for Nucleoprotein Machines receives $16.1 million NIH award

Sigma-Aldrich Corporation announces global release of engineered mammalian cell lines

Sigma-Aldrich Corporation announces global release of engineered mammalian cell lines

Preclinical efficacy data of Sangamo's ZFN based human stem cell therapy for HIV published

Preclinical efficacy data of Sangamo's ZFN based human stem cell therapy for HIV published

Sangamo's ZFP Therapeutics technology highlighted at ASGCT Annual Meeting

Sangamo's ZFP Therapeutics technology highlighted at ASGCT Annual Meeting

Sigma Life Science announces global release of CompoZr Targeted Integration Kit

Sigma Life Science announces global release of CompoZr Targeted Integration Kit

Stem cell scientists receive stimulus grants to study lung and blood disorders

Stem cell scientists receive stimulus grants to study lung and blood disorders

Sigma-Aldrich signs agreement to acquire Ace Animals

Sigma-Aldrich signs agreement to acquire Ace Animals

Sigma Life Science extends portfolio of knockout rat models with the release of ADME/Tox applications

Sigma Life Science extends portfolio of knockout rat models with the release of ADME/Tox applications

Sigma-Aldrich unveils new Sigma Life Science brand and website platform

Sigma-Aldrich unveils new Sigma Life Science brand and website platform

Preliminary data from Phase 1 study of Sangamo BioSciences' SB-728-T announced

Preliminary data from Phase 1 study of Sangamo BioSciences' SB-728-T announced